Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 3,153

Document Document Title
WO/2022/164316A1
The invention relates to a saponin conjugate comprising a saponin derivative based on a saponin comprising a triterpene aglycone and at least one of a first saccharide chain and a second saccharide chain linked to the aglycone core struc...  
WO/2022/157280A1
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of sialylated human milk oligosaccharides (H...  
WO/2022/138748A1
The present invention provides a labeling method that comprises a step for labeling a substrate, which has a carbon-hydrogen bond, with an oxygen isotope with use of a catalyst and an oxidant that is produced from a hypervalent iodine co...  
WO/2022/130322A1
The present invention concerns a method for separating different oligosaccharides having at least one carboxylic acid group, also referred to as charged oligosaccharides. The method allows for the high throughput separation of oligosacch...  
WO/2022/127997A1
The invention relates to the use of ß-galactooligosaccharides of the general formula (ß gal (1→a))p - ß gal (1→b) glu, where p=0 to 6, a=2,3,4 or 6, and b=4 or 6, for producing a cosmetic and/or pharmacologically active compositio...  
WO/2022/117739A1
The present invention relates to storage-stable formulations of oligosaccharide preparations suitable for use in nutritional compositions such as animal feed.  
WO/2022/117074A1
The present application relates to a method for preparing crystalline D-psicose. In the present application, crystalline D-psicose is prepared by means of combining an evaporative crystallization method and a cooling crystallization meth...  
WO/2022/115353A1
Described are methods of reducing exercise-induced injury and/or enhancing muscle recovery after exercise in a subject by administering an effective amount of 2'-fucosyllactose (2'FL). Said effective amount will increases the subject's e...  
WO/2022/107013A1
The present invention relates to a process for the synthesis of Fondaparinux pentasaccharide and its intermediates. Specifically, the present invention relates to a novel catalytic process for the synthesis of Fondaparinux pentasaccharid...  
WO/2022/067131A9
Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for decreasing inflammation for the treatm...  
WO/2022/072323A1
This specification relates to a process for preparing a purified human milk oligosaccharide ("HMO") from an HMO-containing solution (e.g., a fermentation broth) by a process comprising mixed bed ion exchange, and a product of such a proc...  
WO/2022/072333A1
This specification relates to a process for preparing a purified human milk oligosaccharide ("HMO") from an HMO-containing solution (e.g., a fermentation broth) by a process comprising anion ion exchange, cation ion exchange, and mixed b...  
WO/2022/065744A1
Provided according to one embodiment of the present invention are nanoparticles, each nanoparticle comprising a core structure, and a shell structure covering the core structure and separated therefrom by a nanogap, wherein on the surfac...  
WO/2022/067321A1
An improved process for extracting biological material from sugar-bearing plant material. In particular, the sugar-bearing plant material is treated with an extractant solution comprising water and a functionalized amphiphilic polymer, w...  
WO/2020/249584A9
Disclosed is a process for the purification of LNnT (lacto-N-neotetraose) from a fermentation broth, the process comprises subjecting a fermentation broth to a first step of membrane filtration, thereby providing a filtrated solution, su...  
WO/2022/055352A1
The invention relates to a saponin derivative based on a saponin comprising a triterpene aglycone and at least one of a first saccharide chain and a second saccharide chain linked to the aglycone core structure, wherein the saponin deriv...  
WO/2022/056428A1
5'-O-(Acetoacetyl)-2',3'-di-O-acetyluridine is useful in the treatment or prevention of disorders characterized by cerebral metabolic energy failure or diminished mitochondrial energy reserve capacity.  
WO/2022/049307A1
The invention relates to a process for the preparation of a product allulose composition comprising the steps of (a) providing a liquid allulose composition comprising allulose dissolved in water; (b) optionally, heating the liquid allul...  
WO/2022/038198A1
Monosaccharide compounds, in particular deoxy-pentose compounds and preferably 5-azido-5-deoxy-D-arabinofuranose, for use in for use in labelling and/or concentrating and/or targeting and/or diagnosis of cell secretions from eukaryotic c...  
WO/2022/029010A1
Food product, comprising 5.00 to 99.99% by weight of a crystalline beet-sugar sucrose preparation enriched in low-melting sucrose phase (LSP) and 0.01 to 95.00% by weight of at least one food component, and method for its production.  
WO/2022/008693A1
The present invention relates to a process which makes it possible to obtain a plurality of organic compounds that can be used as chemical intermediates through the use of waste cellulosic biomass as a raw material. Through this process ...  
WO/2021/260562A1
The invention relates to a method for synthesising macromolecules made up of units U that are mostly monosaccharides or monosaccharide derivatives, by successive elongation of a first unit U1 attached by a covalent bond to an anchor mole...  
WO/2021/250191A1
The present invention relates to a method for improved demineralization of fermentation broths, including the steps of providing a solution comprising one or more oligosaccharides, carrying out a first membrane filtration and preferably ...  
WO/2021/239813A1
The invention relates to a process for the preparation of a solid allulose material comprising crystalline allulose, the method comprising the steps of (a) providing in an evaporating crystallizer an aqueous mother liquor containing diss...  
WO/2021/231751A1
The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection ...  
WO/2021/148618A9
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a...  
WO/2021/208237A1
An application of a heptose chain-containing oligosaccharide compound in the preparation of a helicobacter pylori vaccine, relating to the field of medicines. A synthetic oligosaccharide chip is prepared by chemically synthesizing differ...  
WO/2021/202883A1
Disclosed herein are genetically modified microorganisms and related methods for the enhanced production and export of oligosaccharides. The microorganisms described herein express major facility superfamily proteins such as CDT-1, which...  
WO/2021/181349A1
The invention relates to a method for selective crystallization of 2'-FL from an aqueous solution comprising 2'-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution.  
WO/2021/183896A1
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modu...  
WO/2021/175878A1
The present invention provides a new type of galacto-oligosaccharide, having a mannose residue instead of a glucose residue at the reducing end. The invention also relates to compositions comprising this galacto-oligosaccharide, its prep...  
WO/2021/172482A1
A method for producing a sugar anhydride, said method comprising: (1) a step for conducting a first heat treatment by heating a polysaccharide having a reducing end at 130-350°C in the presence of an alcohol compound having 1-10 carbon ...  
WO/2021/163778A1
A biodegradable, thermoplastic, nanostructured bioresin composition is described, said composition comprising a) 10-80% by weight, in relation to the total weight of the composition, of a polymer matrix from a renewable source, comprisin...  
WO/2021/160701A1
The invention relates to a crystalline allulose with a defined particle size distribution, to a process for the production and use thereof. The new allulose quality is characterised by the fact that it improves the shelf life of end prod...  
WO/2021/160564A1
Proposed are allulose concentrates in solid amorphous form, which are characterised in that they contain at least approximately 20 wt. % allulose. Also proposed is a method for producing said concentrates.  
WO/2021/158932A1
A glucose in solid form containing a matrix phase and a plurality of carbohydrate crystals within said matrix phase, the matrix phase containing amorphous glucose and water, wherein the carbohydrate crystals comprise glucose and optional...  
WO/2021/034774A9
Disclosed are methods for treating a cancer and/or modulating immune CD4+ T cell mediated therapies comprising administering to a subject a fucose. In one aspect, disclosed herein are methods of modulating major histocompatibility comple...  
WO/2021/148611A1
The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic acid encoding a protein of the MFS superfamily; and methods using...  
WO/2021/148620A1
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a...  
WO/2021/126140A1
An esterification process that uses an acetic acid composition from a wood acetylation process as a reactant. Even though the acetic acid composition contains impurities, such as ethyl acetate, methyl acetate, acetaldehyde, acetone, terp...  
WO/2021/126142A1
An esterification process that uses an acetic acid composition from a wood acetylation process as a reactant. Even though the acetic acid composition contains impurities, such as ethyl acetate, methyl acetate, acetaldehyde, acetone, terp...  
WO/2021/122793A1
The present invention relates to disaccharide compounds and their use as enhancers of transmucosal drug uptake.  
WO/2021/122103A1
The present invention relates to a method for producing a human milk oligosaccharide (HMO) containing at least one HMO compound, characterized in that an aqueous solution containing the at least one HMO compound and at least one acid is ...  
WO/2021/110709A1
Process for the preparation of a galacto-oligosaccharide preparation, which process comprises the step of contacting a lactulose-containing feed with a beta-galactosidase derived from Papiliotrema terrestris. The resulting galacto-oligos...  
WO/2021/107522A2
The present application relates to a novel composition for preparing allulose and a method for preparing allulose by using same  
WO/2021/094133A2
The present invention relates to a method for producing 2'-fucosyllactose, an enzyme selectively cleaving the alpha-1,3-C-O bond of fucosylated carbohydrates and its use for the production of 2' fucosyllactose, a host cell heterologously...  
WO/2021/094459A1
The present invention relates to a method for drying human milk oligosaccharides (HMOs). More specifically, the present invention is related to a method of roller drying or drum drying of human milk oligosaccharides in a simple and econo...  
WO/2021/085317A1
The present invention allows cell culturing while the cells are suspended, and is configured for easy recovery of the cultured cells. An additive for suspension culture according to an embodiment is a medium additive that is added to a m...  
WO/2021/075882A1
The present invention relates to a coagulant that is added to effectively recover a sugar solution from a saccharified product that contains insoluble saccharified residues composed mainly of lignin, and monosaccharides after acidic sacc...  
WO/2021/075538A1
The present invention provides: a crystalline 2,4-crosslinked common intermediate useful for producing a plurality of ENA monomers; a method for stereoselectively producing said intermediate; and a method for efficiently producing indivi...  

Matches 1 - 50 out of 3,153